-+ 0.00%
-+ 0.00%
-+ 0.00%

Electra Therapeutics adopts amended, restated bylaws effective at IPO close

PUBT·09/21/2026 20:03:02
Electra Therapeutics adopts amended, restated bylaws effective at IPO close
  • Electra Therapeutics adopted amended and restated bylaws effective Sept. 21, 2026 in connection with its IPO closing.
  • Changes took effect alongside an amended and restated certificate of incorporation filed in Delaware on the same date.
  • IPO closed Sept. 21, 2026 with 23,333,334 common shares sold at USD 15 per share, raising about USD 350 million gross.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-396646), on September 21, 2026, and is solely responsible for the information contained therein.